Angiogenesis—the formation of new blood vessels from existing vasculature—is essential for tissue growth, wound healing, and regeneration. Blood vessels deliver oxygen, nutrients, and growth factors while removing metabolic waste products. Impaired angiogenesis limits tissue repair capacity, whereas excessive angiogenesis occurs in cancer and pathologic conditions. Research peptides including BPC-157, TB-500, and VEGF-promoting compounds enhance angiogenesis through growth factor signaling, improving tissue repair outcomes.
VEGF and FGF: Master Regulators of Angiogenesis
Vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) are primary angiogenic signals promoting endothelial cell proliferation, migration, and tube formation. VEGF signals through VEGFR1 and VEGFR2 on endothelial cells, activating PI3K/Akt and MEK/ERK pathways driving cell growth and survival. FGF signals through fibroblast growth factor receptors (FGFR) with similar downstream effects. BPC-157 enhances VEGF and FGF production through complex signaling mechanisms involving growth factor receptor transactivation and NO production. This FGF/VEGF upregulation drives robust angiogenesis supporting tissue repair and regeneration across multiple organ systems.
Endothelial Cell Functions Beyond Vessel Formation
Beyond structural tube formation, vascular endothelial cells produce critical angiocrine factors regulating tissue repair and metabolism. Endothelial-derived VEGF, FGF, and angiopoietins support fibroblast proliferation and collagen synthesis. Endothelial cells produce anticoagulant substances (thrombomodulin, protein C) maintaining blood fluidity and anti-inflammatory factors reducing local inflammation. Endothelial dysfunction characterized by impaired vasodilation (NO deficiency), increased permeability, and pro-thrombotic phenotype impairs tissue repair. Peptides enhancing endothelial function and NO production improve tissue perfusion and oxygenation supporting repair processes.
References
Carmeliet, P., & Jain, R. K. (2011). Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nature Reviews Drug Discovery, 10(6), 417-427. PMID: 21629292
Lamalice, L., Le Boeuf, F., & Huot, J. (2007). Endothelial cell migration during angiogenesis. Circulation Research, 100(5), 782-794. PMID: 17395883
Simons, M., & Ware, J. A. (2003). Therapeutic angiogenesis in cardiovascular disease. Nature Reviews Drug Discovery, 2(11), 863-871. PMID: 14668807
